Bloomberg News
@Bloomberg-News·2.8M subscribers·40.1K videos
Biden Tours NIH Lab That Developed Moderna's Covid 19 Vaccine
Posted
February 11, 2021
Views
2,969
Likes
41
Comments
16
Engagement
February 11, 2021
2,969
41
16
1.92%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
0:47Now PlayingPresident Joe Biden visited some of the nation's leading scientists on the frontlines of the fight against COVID-19 on Thursday, as his administration looks to boost supplies of vaccines to end the pandemic.
Biden toured the Viral Pathogenesis Laboratory at the sprawling National Institutes of Health complex just outside Washington that created the COVID-19 vaccine now manufactured by Moderna and being rolled out in the U.S. and other countries. He was also set to address the agency's team of researchers and scientists, who have investigated treatments for COVID-19 and other dangerous diseases.
The U.S. is on pace to exceed Biden's goal of administering 100 million vaccine doses in his first 100 days in office, with more than 26 million shots delivered in his first three weeks. Meanwhile, Biden is moving to ease supply bottlenecks and ensure the nation has enough of the current two-dose vaccines to protect 300 million Americans by the end of summer.
The pace of injections could increase further if a third coronavirus vaccine from drugmaker Johnson & Johnson receives approval from the Food and Drug Administration.
The Viral Pathogenesis Laboratory is led by Dr. Barney Graham, whose team made critical discoveries years ago that laid the groundwork for rapid development of that and other COVID-19 vaccines. Before the pandemic erupted, one of Graham’s research fellows, Dr. Kizzmekia Corbett, had been using those earlier findings to develop a vaccine for MERS, a cousin of COVID-19.
Armed with their prior research, Corbett and Graham had a head start when Chinese scientists shared the genetic map of the new coronavirus in January 2020. They already knew how to make spike proteins, which coat the surface of the new coronavirus and its MERS relative, that were stable enough to be used as a key vaccine ingredient.
Within days, the NIH had sent instructions to Moderna to brew up doses, and Corbett and her colleagues were setting up the key lab and animal tests that would eventually prove they were on the right track.
Subscribe to our YouTube channel
Bloomberg Quicktake brings you live global news and original shows spanning business, technology, politics and culture. Make sense of the stories changing your business and your world.
To watch complete coverage on Bloomberg Quicktake 24/7, visit or watch on Apple TV, Roku, Samsung Smart TV, Fire TV and Android TV on the Bloomberg app.
Have a story to tell? Fill out this survey for a chance to have it featured on Bloomberg Quicktake
Connect with us on…
Breaking News on YouTube
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
